Oncolytic virotherapy.
D. Cervantes-García,
R. Ortíz-López,
N. Mayek-Pérez,
A. Rojas-Martínez
|
9 |
2008 |
9
2008
|
Prevalence of non-alcoholic fatty liver disease: population based study.
10 auth.
D. Amarapurkar,
Praful M. Kamani,
N. Patel,
P. Gupte,
Pravin Kumar,
S. Agal,
...
R. Baijal,
S. Lala,
Dinesh Chaudhary,
Anjali A. Deshpande
|
8 |
2007 |
8
2007
|
Bile Acid Physiology.
7 auth.
A. Di Ciaula,
G. Garruti,
Raquel Lunardi Baccetto,
E. Molina-Molina,
L. Bonfrate,
D. Q. Wang,
...
P. Portincasa
|
8 |
2017 |
8
2017
|
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).
S. Bellentani,
M. Marino
|
8 |
2009 |
8
2009
|
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.
7 auth.
V. Wong,
Grace Lai-Hung Won,
A. Chim,
W. Chu,
D. Yeung,
K. Li,
...
H. Chan
|
8 |
2013 |
8
2013
|
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis.
A. Loaeza-del-Castillo,
F. Paz-Pineda,
Edgar Oviedo-Cárdenas,
F. Sánchez-Ávila,
F. Vargas‐Vorácková
|
7 |
2008 |
7
2008
|
A multi-society Delphi consensus statement on new fatty liver disease nomenclature.
53 auth.
M. Rinella,
J. Lazarus,
V. Ratziu,
S. Francque,
A. Sanyal,
F. Kanwal,
D. Romero,
M. Abdelmalek,
Q. Anstee,
J. Arab,
M. Arrese,
R. Bataller,
U. Beuers,
J. Boursier,
E. Bugianesi,
...
C. Byrne,
G. E. C. Narro,
A. Chowdhury,
H. Cortez‐Pinto,
D. Cryer,
K. Cusi,
Mohamed El‐Kassas,
S. Klein,
Wayne Eskridge,
Jian-Gao Fan,
S. Gawrieh,
C. Guy,
S. Harrison,
Seung-Up Kim,
B. Koot,
Marko Korenjak,
K. Kowdley,
F. Lacaille,
R. Loomba,
R. Mitchell-Thain,
T. Morgan,
Elisabeth Powell,
M. Roden,
M. Romero‐Gomez,
Marcelo Silva,
S. Singh,
S. Sookoian,
C. W. Spearman,
D. Tiniakos,
Luca Valenti,
M. Vos,
V. Wong,
S. Xanthakos,
Y. Yılmaz,
Z. Younossi,
Ansley Hobbs,
Marcela Villota-Rivas,
P. Newsome
|
7 |
2023 |
7
2023
|
Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.
Y. Gutiérrez-Grobe,
G. Ponciano-Rodríguez,
M. Ramos,
M. Uribe,
N. Méndez-Sánchez
|
7 |
2010 |
7
2010
|
The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
J. A. González-Regueiro,
L. Moreno-Castañeda,
M. Uribe,
N. Chavez-Tapia
|
7 |
2017 |
7
2017
|
The importance of redox state in liver damage.
L. Cesaratto,
C. Vascotto,
Sebastián D. Calligaris,
G. Tell
|
7 |
2004 |
7
2004
|
Metabolic syndrome and non-alcoholic fatty liver disease.
P. Almeda-Valdés,
D. Cuevas-Ramos,
C. Aguilar-Salinas
|
7 |
2009 |
7
2009
|
The Role of the Gut Microbiota in Bile Acid Metabolism.
O. Ramirez-Perez,
V. Cruz-Ramon,
Paulina Chinchilla-López,
N. Méndez-Sánchez
|
7 |
2017 |
7
2017
|
Liver fibrosis and inflammation. A review.
D. Kershenobich Stalnikowitz,
Alan Bonder Weissbrod
|
7 |
2003 |
7
2003
|
What is changing in indications and treatment of hepatic hemangiomas. A review.
8 auth.
A. Toro,
A. Mahfouz,
A. Ardiri,
M. Malaguarnera,
G. Malaguarnera,
F. Loria,
...
G. Bertino,
I. Di Carlo
|
7 |
2014 |
7
2014
|
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.
7 auth.
Lisa B Van Wagner,
Sean Koppe,
E. Brunt,
J. Gottstein,
Konstantina Gardikiotes,
R. Green,
...
M. Rinella
|
7 |
2011 |
7
2011
|
